Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dan Hong injection in coronary heart disease
ChiCTR-TRC-14004100Phase 4Completed
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Jan 2014
- Countries
- 1
01
Overview
Phase 4, open-label trial of danhong injection in coronary arteriosclerosis, angina pectoris and unstable angina (6 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Number and function of endothelial progenitor cells, Number of circulating endothelial cells and 3 more. Started Jan 2014; status: completed.
02
Drugs
danhong injection
03
Conditions
coronary arteriosclerosisangina pectorisunstable angina
Beyond the preview
Go deeper on ChiCTR-TRC-14004100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004100.